IL157026A0 - Crystal modification of a cyclic depsipeptide having improved strength - Google Patents

Crystal modification of a cyclic depsipeptide having improved strength

Info

Publication number
IL157026A0
IL157026A0 IL15702602A IL15702602A IL157026A0 IL 157026 A0 IL157026 A0 IL 157026A0 IL 15702602 A IL15702602 A IL 15702602A IL 15702602 A IL15702602 A IL 15702602A IL 157026 A0 IL157026 A0 IL 157026A0
Authority
IL
Israel
Prior art keywords
cyclic depsipeptide
improved strength
crystal modification
depsipeptide
cyclic
Prior art date
Application number
IL15702602A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL157026A0 publication Critical patent/IL157026A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15702602A 2001-02-01 2002-01-21 Crystal modification of a cyclic depsipeptide having improved strength IL157026A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104362A DE10104362A1 (de) 2001-02-01 2001-02-01 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
PCT/EP2002/000541 WO2002066048A1 (de) 2001-02-01 2002-01-21 Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit

Publications (1)

Publication Number Publication Date
IL157026A0 true IL157026A0 (en) 2004-02-08

Family

ID=7672376

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15702602A IL157026A0 (en) 2001-02-01 2002-01-21 Crystal modification of a cyclic depsipeptide having improved strength
IL157026A IL157026A (en) 2001-02-01 2003-07-21 Use of Cyclic Depseptide with Improved Strength for the Preparation of a Pharmaceutical Preparation for the Treatment of Pathogenic Endoprosites

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157026A IL157026A (en) 2001-02-01 2003-07-21 Use of Cyclic Depseptide with Improved Strength for the Preparation of a Pharmaceutical Preparation for the Treatment of Pathogenic Endoprosites

Country Status (27)

Country Link
US (1) US20040115483A1 (enExample)
EP (1) EP1357932B1 (enExample)
JP (1) JP2004525111A (enExample)
KR (2) KR20030081378A (enExample)
CN (1) CN1278735C (enExample)
AT (1) ATE284703T1 (enExample)
AU (1) AU2002226415B2 (enExample)
BR (1) BRPI0206841B8 (enExample)
CA (1) CA2436832C (enExample)
CR (1) CR7039A (enExample)
CZ (1) CZ299564B6 (enExample)
DE (2) DE10104362A1 (enExample)
EE (1) EE05490B1 (enExample)
ES (1) ES2233805T3 (enExample)
HR (1) HRP20030635A2 (enExample)
HU (1) HU229229B1 (enExample)
IL (2) IL157026A0 (enExample)
MX (1) MXPA03006866A (enExample)
NO (1) NO331289B1 (enExample)
NZ (1) NZ527230A (enExample)
PL (1) PL213106B1 (enExample)
PT (1) PT1357932E (enExample)
RU (1) RU2300390C2 (enExample)
SK (1) SK286280B6 (enExample)
UA (1) UA74623C2 (enExample)
WO (1) WO2002066048A1 (enExample)
ZA (1) ZA200305864B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003546A1 (en) * 2006-06-29 2008-01-03 Dunbar Kimberly L Animated digital charted yarncraft instruction
HUE055535T2 (hu) 2015-05-20 2021-12-28 Boehringer Ingelheim Animal Health Usa Inc Féreghajtó depszipeptid-vegyületek
CN108699052B (zh) 2015-12-28 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096907A (en) * 1981-04-22 1982-10-27 Exxon Research Engineering Co Distillation column with steam stripping
NZ249588A (en) * 1992-03-17 1996-08-27 Fujisawa Pharmaceutical Co Anthelmintic agent
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
JP3985050B2 (ja) * 1995-06-30 2007-10-03 アステラス製薬株式会社 デプシペプチド誘導体その製造法およびその新規中間体
NZ318515A (en) * 1995-09-22 2000-05-26 Bayer Ag Cyclodepsipeptide PF1022 derivatives and compositions thereof
WO1999024412A1 (en) * 1997-11-10 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. Novel crystal of depsipeptide derivative and process for producing the same
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere

Also Published As

Publication number Publication date
RU2300390C2 (ru) 2007-06-10
KR20030081378A (ko) 2003-10-17
EE05490B1 (et) 2011-12-15
ATE284703T1 (de) 2005-01-15
PL213106B1 (pl) 2013-01-31
WO2002066048A1 (de) 2002-08-29
CN1278735C (zh) 2006-10-11
EP1357932A1 (de) 2003-11-05
UA74623C2 (en) 2006-01-16
NZ527230A (en) 2005-04-29
BRPI0206841B1 (pt) 2018-02-14
DE10104362A1 (de) 2002-08-08
HU229229B1 (en) 2013-09-30
EP1357932B1 (de) 2004-12-15
SK9882003A3 (en) 2003-12-02
HUP0302880A3 (en) 2005-05-30
WO2002066048A8 (de) 2003-11-20
CZ20032063A3 (cs) 2003-11-12
CA2436832C (en) 2013-06-11
CZ299564B6 (cs) 2008-09-03
SK286280B6 (sk) 2008-06-06
AU2002226415B2 (en) 2007-03-22
US20040115483A1 (en) 2004-06-17
BR0206841A (pt) 2004-02-25
HK1075013A1 (en) 2005-12-02
IL157026A (en) 2010-11-30
NO20033413D0 (no) 2003-07-30
CN1592631A (zh) 2005-03-09
EE200300365A (et) 2003-10-15
HRP20030635A2 (en) 2005-10-31
CA2436832A1 (en) 2002-08-29
JP2004525111A (ja) 2004-08-19
MXPA03006866A (es) 2004-05-31
PT1357932E (pt) 2005-04-29
HUP0302880A2 (hu) 2003-12-29
KR20090041451A (ko) 2009-04-28
NO331289B1 (no) 2011-11-21
NO20033413L (no) 2003-09-26
RU2003126589A (ru) 2005-02-27
CR7039A (es) 2004-06-08
PL362389A1 (en) 2004-11-02
ZA200305864B (en) 2004-08-27
BRPI0206841B8 (pt) 2021-05-25
DE50201777D1 (de) 2005-01-20
ES2233805T3 (es) 2005-06-16

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
SE0200920D0 (sv) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200508214A (en) Novel compounds
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
SE0104140D0 (sv) Novel Compounds
TW200616995A (en) Novel compounds
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03009602A (es) Analogos de nociceptina.
MXPA04006041A (es) Antivirales de piridoquinoxalina.
GR20020100478A (el) Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης
IL157026A0 (en) Crystal modification of a cyclic depsipeptide having improved strength
MXPA03005980A (es) Composiciones para administracion nasal de insulina.
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
TW200740781A (en) Novel compounds
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA04005151A (es) Compuestos terapeuticos.
DE60212130D1 (en) Carvedilolpolymorph